Abstract

Neoarsphenamine (NARS), an organic trivalent arsenical compound, is a sulfhydryl-binding agent whose pharmalogical action in humans is well documented. Because it is a sulfhydryl-binding agent, the possibility that it would sensitize anoxic cells to ionizing radiation was investigated with the idea that such a sensitization could overcome the relative protection that severely hypoxic cells enjoy in certain parts of most human cancers. Micrococcus sodonensis and Escherichia coli K-12 AB1157 were both tested. Though both bacteria were sensitized, the latter is especially interesting because no sensitization occurred when NARS was used in an oxygenated medium. A sensitization factor [defined as the ratio of the slopes, where the slope of the curve refers to the relationship of the surviving fraction (ordinate) to the dose in kilorads (abscessa)] of approximately 2.2 was obtained with AB1157. The effect was reversed by an excess of cysteine added immediately before x-irradiation but was not lost by pre-x-ray ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.